FDA-Drug2026-01-21Class IIICHEMICAL
Taro Pharmaceuticals fluocinolone acetonide topical solution recalled for failed impurity specifications
OTHERNationwide distribution
Stop using recalled fluocinolone acetonide solution
Taro Pharmaceuticals is recalling specific lots of fluocinolone acetonide topical solution (0.01%) because testing found higher-than-allowed levels of an impurity. The affected lots were distributed nationwide. No injuries have been reported.
- Check your fluocinolone acetonide bottle for lot number AD81290, AD81291, AD81292, or AD81293 with expiration date 1/31/2027.
- Stop using the medication if your bottle matches these lot numbers.
- Contact your pharmacy or doctor for a replacement or alternative treatment.
- Do not flush the medication down the toilet; ask your pharmacy how to dispose of it safely.
Hazard
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
Sold states
Nationwide within the USA
Affected count
24,624 bottles
Manufactured in
2 Independence Way, Princeton, NJ, United States
Products
Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0256-2026More SUN PHARMACEUTICAL INDUSTRIES INC recalls
- FDA-Drug2026-06-17Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles
- FDA-Drug2026-06-17Sun Pharmaceutical doxorubicin injection recalled for glass particles
- FDA-Drug2026-04-22Taro Fluocinonide 0.05% Cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide 0.05% cream recalled for viscosity defect
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief